Sartorius Aktiengesellschaft (ETR:SRT3)
242.00
-7.00 (-2.81%)
Feb 21, 2025, 5:35 PM CET
Sartorius Aktiengesellschaft Employees
Sartorius Aktiengesellschaft had 13,528 employees as of December 31, 2024. The number of employees decreased by 1,086 or -7.43% compared to the previous year.
Employees
13,528
Change (1Y)
-1,086
Growth (1Y)
-7.43%
Revenue / Employee
€256,561
Profits / Employee
€6,375
Market Cap
15.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13,528 | -1,086 | -7.43% |
Dec 31, 2023 | 14,614 | -1,328 | -8.33% |
Dec 31, 2022 | 15,942 | 2,110 | 15.25% |
Dec 31, 2021 | 13,832 | 3,195 | 30.04% |
Dec 31, 2020 | 10,637 | 1,621 | 17.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 62,908 |
Bayer Aktiengesellschaft | 96,931 |
Fresenius SE & Co. KGaA | 193,865 |
Fresenius Medical Care AG | 119,845 |
Carl Zeiss Meditec AG | 5,730 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
Fielmann Group AG | 23,412 |
Sartorius Aktiengesellschaft News
- 5 days ago - EQS-News: Sartorius releases Annual Report for 2024 - Wallstreet:Online
- 15 days ago - EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share - Wallstreet:Online
- 25 days ago - Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Sartorius lifts U.S. peers after 2024 results - Seeking Alpha
- 25 days ago - Sartorius Aktiengesellschaft Non-GAAP EPS of €4.05, revenue of €3.38B; initiates FY25 soft outlook - Seeking Alpha
- 25 days ago - Sartorius Vz. Surges in Q4, Hits 2024 Targets with Positive Momentum - Wallstreet:Online
- 25 days ago - EQS-News: Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved - Wallstreet:Online
- 2 months ago - Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage - Seeking Alpha